• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TEPHA, INC. - 3005670760 GALAFLEX 3DR; ABSORBABLE MESH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TEPHA, INC. - 3005670760 GALAFLEX 3DR; ABSORBABLE MESH Back to Search Results
Model Number 100043-02
Medical Device Problem Code Patient-Device Incompatibility (2682)
Health Effect - Clinical Code Seroma (2069)
Date of Event 04/08/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As reported patient had serous yellow fluid and underwent explant post implant of galaflex 3dr in the breast.Based on the information provided, no conclusions can be made as to what if any extent the mesh caused or contribute to the patients post operative course.Seroma is known inherent risk of the surgery/use and is listed in the adverse reactions section of the instructions-for-use supplied with the device, as a possible complication.Review of manufacturing records confirms product was manufactured to specification.To date, this is the only reported complaint for this manufacturing lot of 384 units.Note: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event or Problem Description
As reported, the patient had a bilateral breast implant exchange with capsulectomy and placement of cohesive implants on (b)(6) 2025.Patient came in for follow up on (b)(6) 2025 for bilateral swelling.No redness, warmth, or bilateral swelling found.It ws reported that on (b)(6) 2025 the patient went into or fpr what was thought to be (r) breast hematoma evacuation, but once opened no blood was found, only a significant amount of serous yellow fluid; found on both sides, but more so on the (r) than the (l).The surgeon removed both galaflex meshes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GALAFLEX 3DR
Common Device Name
ABSORBABLE MESH
Manufacturer (Section D)
TEPHA, INC. - 3005670760
99 hayden ave suite 360
lexington MA 02421
Manufacturer (Section G)
TEPHA, INC. - 3005670760
99 hayden ave suite 360
lexington MA 02421
Manufacturer Contact
andrew topoulos
100 crossings blvd.
warwick, RI 02886
8005566756
MDR Report Key21937464
Report Number1213643-2025-00352
Device Sequence Number7985205
Product Code OOD
UDI-Device Identifier00810054980018
UDI-Public(01)00810054980018(17)270802(10)LXHW0020
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K162922
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2025
Device Explanted Year2025
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 04/14/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model Number100043-02
Device Catalogue NumberFR3D02
Device Lot NumberLXHW0020
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/08/2025
Initial Report FDA Received Date04/30/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured01/11/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexFemale
-
-